XPH

SPDR$62.09-1.34 (-2.11%)
AUM $501.2MER 0.35%NAV $63.44Holdings 60

Price Chart

Key Statistics

Previous Close

$63.42

Day Range

$61.96$63.87

52-Week Range

$51.36$74.06

Avg Volume

266.2K

Dividend Yield

0.84%

Expense Ratio

0.35%

AUM

$501.2M

Shares Outstanding

4.0M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States100.00%

Fund Information

Issuer
SPDR
Category
Healthcare
Inception Date
Jun 19, 2006
Exchange
NYSE_ARCA
Description
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$46.92B
VHTVanguard Health Care ETF$20.80B
VTWOVanguard Russell 2000 ETF$16.80B
RWLInvesco S&P 500 Revenue ETF$10.01B
XBIState Street SPDR S&P Biotech ETF$9.64B

The State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund issued by SPDR that launched on Jun 19, 2006. It currently manages $501.2M in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 60 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 27.3% of the fund

RankSymbolNameWeight %SharesMarket Value
1XERSXERIS BIOPHARMA HOLDINGS INC4.63%1,405,498$23.2M
2MANEVERADERMICS INC2.68%108,722$13.4M
3AMRXAMNEAL PHARMACEUTICALS INC2.67%628,196$13.4M
4VTRSVIATRIS INC2.59%656,751$13.0M
5LLYELI LILLY + CO2.58%9,639$12.9M
6MAZEMAZE THERAPEUTICS INC2.52%392,258$12.6M
7PRGOPERRIGO CO PLC2.40%755,675$12.0M
8RPRXROYALTY PHARMA PLC CL A2.40%178,848$12.0M
9ELANELANCO ANIMAL HEALTH INC2.40%460,144$12.0M
10ZTSZOETIS INC2.37%147,816$11.9M
11COLLCOLLEGIUM PHARMACEUTICAL INC2.27%453,046$11.3M
12ETONETON PHARMACEUTICALS INC2.24%184,198$11.2M
13PBHPRESTIGE CONSUMER HEALTHCARE2.19%222,514$11.0M
14OGNORGANON + CO2.19%792,714$11.0M
15JNJJOHNSON + JOHNSON2.15%40,573$10.8M
Page 1 of 2

Detailed Returns

PeriodReturnETF
1D
-2.11%
1W
-4.91%
1M
-0.88%
3M
-14.49%
6M
+7.01%
YTD
+12.57%
1Y
+16.63%
3Y
+67.48%
5Y
+29.80%

Moving Averages

20-Day MA

$64.97

Below 20-Day MA
50-Day MA

$64.88

Below 50-Day MA
200-Day MA

$62.40

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$74.06

Current Price

$62.09

52-Week Low

$51.36

$51.36$74.06

Current Yield

0.84%

Annual Dividend

$0.2747

Frequency

4x/year

Last Ex-Date

Sep 21, 2026

Dividend History

Ex-DateAmountPay Date
Sep 21, 2026$0.0416Sep 23, 2026
Jun 22, 2026$0.0590Jun 24, 2026
Mar 23, 2026$0.0610Mar 25, 2026
Dec 22, 2025$0.1130Dec 24, 2025
Dec 22, 2025$0.1130Dec 24, 2025
Sep 22, 2025$0.1026Sep 24, 2025
Sep 22, 2025$0.1026Sep 24, 2025
Jun 23, 2025$0.0959Jun 25, 2025
Mar 24, 2025$0.1533Mar 26, 2025
Mar 24, 2025$0.1533Mar 26, 2025
Dec 23, 2024$0.1548Dec 26, 2024
Dec 23, 2024$0.1548Dec 26, 2024
Sep 23, 2024$0.1947Sep 25, 2024
Sep 23, 2024$0.1947Sep 25, 2024
Jun 24, 2024$0.1557Jun 26, 2024
Jun 24, 2024$0.1557Jun 26, 2024
Mar 18, 2024$0.1730Mar 21, 2024
Mar 18, 2024$0.1730Mar 21, 2024
Dec 18, 2023$0.1744Dec 21, 2023
Dec 18, 2023$0.1744Dec 21, 2023

Dividend Payments Over Time

Category Comparison

MetricXPHHealthcare(212 ETFs)Equal Weight(109 ETFs)
Fund Info
Expense Ratio0.35%0.68%0.68%
AUM$501.2M$842.0M$1.70B
Dividend Yield0.84%5.54%2.87%
Avg Volume266.2K257.4K665.9K
Holdings60124192
Performance
1-Month Return-3.31%-7.05%-7.34%
6-Month Return+6.49%-1.75%-4.43%
YTD Return+10.96%+2.72%+2.52%
1-Year Return+9.40%+0.26%-0.99%

Compare with Another ETF

Search for an ETF to compare with XPH:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.